Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

Objective:  To describe the 12‐month and lifetime prevalence rates of mood, anxiety and alcohol disorders in six European countries.

[1]  R. Kessler,et al.  Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project , 2004, Acta psychiatrica Scandinavica. Supplementum.

[2]  G. de Girolamo,et al.  Community surveys of mental disorders: recent achievements and works in progress , 2003 .

[3]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[4]  M. First DSM‐IV and Psychiatric Epidemiology , 2003 .

[5]  R. Kessler,et al.  The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methods , 2002, International journal of methods in psychiatric research.

[6]  C. Dowrick,et al.  Depressive disorders in Europe: prevalence figures from the ODIN study , 2001, British Journal of Psychiatry.

[7]  F. Smit,et al.  Psychiatric and sociodemographic predictors of attrition in a longitudinal study: The Netherlands Mental Health Survey and Incidence Study (NEMESIS). , 2000, American journal of epidemiology.

[8]  J. Kaprio,et al.  The 12‐month prevalence and risk factors for major depressive episode in Finland: representative sample of 5993 adults , 2000, Acta psychiatrica Scandinavica.

[9]  G. Andrews,et al.  Australia's Mental Health: An Overview of the General Population Survey* , 2000, The Australian and New Zealand journal of psychiatry.

[10]  Olga V. Demler,et al.  Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. , 2000, Bulletin of the World Health Organization.

[11]  J. Lépine,et al.  DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. , 1999, International clinical psychopharmacology.

[12]  R. Bijl,et al.  Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS) , 1998, Social Psychiatry and Psychiatric Epidemiology.

[13]  P Bebbington,et al.  The National Psychiatric Morbidity Surveys of Great Britain – initial findings from the Household Survey , 1997, Psychological Medicine.

[14]  W. Rein,et al.  Clinical update on amisulpride in deficit schizophrenia , 1997, International clinical psychopharmacology.

[15]  J. Lépine,et al.  Depression in the community: the first pan‐European study DEPRES (Depression Research in European Society) , 1997, International clinical psychopharmacology.

[16]  D. Offord,et al.  One-Year Prevalence of Psychiatric Disorder in Ontarians 15 to 64 Years of Age , 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[17]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.

[18]  J. Anthony,et al.  Psychopathology and attrition in the epidemiologic catchment area surveys. , 1992, American journal of epidemiology.